| Patent | Date |
|---|
Concomitant Administration Of Glucocorticoid Receptor Modulators And Cyp3a Inhibitors
App 20220088036 - Belanoff; Joseph K. | 2022-03-24 |
Methods for treating Cushing's syndrome
Grant 11,268,145 - Belanoff , et al. March 8, 2 | 2022-03-08 |
Use Of Glucocorticoid Receptor Antagonists In Combination With Glucocorticoids To Treat Adrenal Insufficiency
App 20220062297 - MORAITIS; Andreas G. ; et al. | 2022-03-03 |
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
Grant 11,202,784 - Moraitis , et al. December 21, 2 | 2021-12-21 |
Use Of Glucocorticoid Receptor Antagonists For The Treatment Of Amyotrophic Lateral Sclerosis
App 20210128584 - Belanoff; Joseph K. | 2021-05-06 |
Fatty Liver Disease Treatment Using Glucocorticoid And Mineralocorticoid Receptor Antagonists
App 20210085682 - Belanoff; Joseph K. ; et al. | 2021-03-25 |
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
Grant 10,881,660 - Belanoff , et al. January 5, 2 | 2021-01-05 |
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
Grant 10,842,800 - Belanoff November 24, 2 | 2020-11-24 |
Methods For Diagnosing And Assessing Treatment For Cushing's Syndrome
App 20200216905 - Belanoff; Joseph K. ; et al. | 2020-07-09 |
Use Of Glucocorticoid Receptor Antagonists In Combination With Glucocorticoids To Treat Adrenal Insufficiency
App 20200206243 - MORAITIS; Andreas G. ; et al. | 2020-07-02 |
Concomitant Administration Of Glucocorticoid Receptor Modulators And Cyp3a Inhibitors
App 20200147107 - Belanoff; Joseph K. | 2020-05-14 |
Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency
Grant 10,610,534 - Moraitis , et al. | 2020-04-07 |
Methods for diagnosing and assessing treatment for Cushing's syndrome
Grant 10,604,807 - Belanoff , et al. | 2020-03-31 |
Fatty Liver Disease Treatment Using Glucocorticoid And Mineralocorticoid Receptor Antagonists
App 20190151318 - Belanoff; Joseph K. ; et al. | 2019-05-23 |
Concomitant Administration Of Glucocorticoid Receptor Modulators And Cyp3a Inhibitors
App 20190117676 - Belanoff; Joseph K. | 2019-04-25 |
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
Grant 10,238,659 - Belanoff , et al. | 2019-03-26 |
Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors
Grant 10,195,214 - Belanoff Fe | 2019-02-05 |
Methods For Diagnosing And Assessing Treatment For Cushing's Syndrome
App 20180291451 - Belanoff; Joseph K. ; et al. | 2018-10-11 |
Use Of Glucocorticoid Receptor Antagonist And Somatostatin Analogues To Treat Acth-secreting Tumors
App 20180125856 - Moraitis; Andreas G. ; et al. | 2018-05-10 |
Methods For Treating And Diagnosing Cushing's Syndrome
App 20180100179 - Belanoff; Joseph K. ; et al. | 2018-04-12 |
Use Of Glucocorticoid Receptor Antagonists In Combination With Glucocorticoids To Treat Adrenal Insufficiency
App 20180078565 - MORAITIS; Andreas G. ; et al. | 2018-03-22 |
Concomitant Administration Of Glucocorticoid Receptor Modulators And Cyp3a Inhibitors
App 20170326157 - Belanoff; Joseph K. | 2017-11-16 |
Concomitant Administration Of Glucocorticoid Receptor Modulators And Cyp3a Or Steroidogenesis Inhibitors
App 20170281651 - Belanoff; Joseph K. | 2017-10-05 |
Fatty Liver Disease Treatment Using Glucocorticoid And Mineralocorticoid Receptor Antagonists
App 20160106749 - Belanoff; Joseph K. ; et al. | 2016-04-21 |
Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
Grant 8,921,348 - Belanoff December 30, 2 | 2014-12-30 |
Optimizing Mifepristone Levels In Plasma Serum Of Patients Suffering From Mental Disorders Treatable With Glucocorticoid Receptor Antagonists
App 20140162993 - Belanoff; Joseph K. | 2014-06-12 |
Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
Grant 8,741,880 - Belanoff June 3, 2 | 2014-06-03 |
Use Of Mifepristone For The Treatment Of Amyotrophic Lateral Sclerosis
App 20140005158 - Belanoff; Joseph K. | 2014-01-02 |
Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
Grant 8,598,149 - Belanoff December 3, 2 | 2013-12-03 |
Methods for treating psychosis associated with interferson-.alpha. therapy
Grant 8,476,254 - Belanoff July 2, 2 | 2013-07-02 |
Methods for treating migraine
Grant 8,450,379 - Belanoff May 28, 2 | 2013-05-28 |
Antiglucocorticoids for the treatment of catatonia
Grant 8,097,606 - Belanoff January 17, 2 | 2012-01-17 |
Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants
App 20110144072 - Belanoff; Joseph K. | 2011-06-16 |
Methods for treating delirium using glucocorticoid receptor-specific antagonists
Grant 7,884,091 - Belanoff February 8, 2 | 2011-02-08 |
Optimizing Mifepristone Levels In Plasma Serum Of Patients Suffering From Mental Disorders Treatable With Glucocorticoid Receptor Antagonists
App 20090062248 - Belanoff; Joseph K. | 2009-03-05 |
Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants
App 20090029959 - Belanoff; Joseph K. | 2009-01-29 |
Methods for inhibiting cognitive deterioration in adults with down's syndrome
Grant 7,402,578 - Belanoff July 22, 2 | 2008-07-22 |
Methods for treating gastroesophageal reflux disease
Grant 7,361,646 - Belanoff April 22, 2 | 2008-04-22 |
Methods for increasing the therapeutic response to electroconvulsive therapy
Grant 7,326,697 - Schatzberg , et al. February 5, 2 | 2008-02-05 |
Methods for treating delirium glucocorticoid receptor-specific antagonists
Grant 7,163,934 - Belanoff January 16, 2 | 2007-01-16 |
Methods For Treating Delirium Using Glucocorticoid Receptor-specific Antagonists
App 20060194713 - Belanoff; Joseph K. | 2006-08-31 |
Methods for treating psychosis associated with interferson-alpha therapy
App 20060063748 - Belanoff; Joseph K. | 2006-03-23 |
Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
Grant 6,964,953 - Belanoff November 15, 2 | 2005-11-15 |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability stan-261con
App 20050124533 - Schatzberg, Alan F. ; et al. | 2005-06-09 |
Antiglucocorticoids for the treatment of catatonia
App 20050080066 - Belanoff, Joseph K. | 2005-04-14 |
Antiglucocorticoids for the treatment of postpartum psychosis
App 20040229855 - Belanoff, Joseph K. | 2004-11-18 |
Methods for treating gastroesophageal reflux disease
App 20040167110 - Belanoff, Joseph K. | 2004-08-26 |
Methods for treating migraine
App 20040132703 - Belanoff, Joseph K. | 2004-07-08 |
Methods for treating delirium glucocorticoid receptor- specific antagonists
App 20040029848 - Belanoff, Joseph K. | 2004-02-12 |
Methods for increasing the therapeutic response to electroconvulsive therapy
App 20040029849 - Schatzberg, Alan F. ; et al. | 2004-02-12 |
Methods for treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist
App 20040019028 - Schatzberg, Alan F. ; et al. | 2004-01-29 |
Methods for preventing antipsychotic-induced weight gain
Grant 6,680,310 - Belanoff , et al. January 20, 2 | 2004-01-20 |
Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist
Grant 6,620,802 - Schatzberg , et al. September 16, 2 | 2003-09-16 |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
App 20030162695 - Schatzberg, Alan F. ; et al. | 2003-08-28 |
Methods for inhibiting cognitive deterioration in adults with down's syndrome
App 20030064974 - Belanoff, Joseph K. | 2003-04-03 |
Methods for preventing antipsychotic-induced weight gain
App 20030027802 - Belanoff, Joseph K. ; et al. | 2003-02-06 |
Glucocorticoid blocking agents for increasing blood-brain barrier permeability
App 20020065259 - Schatzberg, Alan F. ; et al. | 2002-05-30 |
Methods for treating psychosis associated with glucocorticoid related dysfunction
Grant 6,150,349 - Schatzberg , et al. November 21, 2 | 2000-11-21 |
| 